VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.590
-0.005 (-0.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.585
-0.005 (-0.88%)
After-hours: Mar 9, 2026, 5:28 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $19.67 million as of March 9, 2026. Its market cap has decreased by -50.62% in one year.
Market Cap
19.67M
Enterprise Value
-9.68M
1-Year Change
-50.62%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $19.67M, a decrease of -91.44%. That is a compound annual growth rate of -33.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 21.26M |
| Polyrizon | 20.90M |
| Reviva Pharmaceuticals Holdings | 20.87M |
| NanoViricides | 20.72M |
| Lexaria Bioscience | 20.63M |
| Genenta Science | 20.15M |
| Intensity Therapeutics | 20.14M |
| Allarity Therapeutics | 19.94M |